www.scientificamerican.com

www.scientificamerican.com
Share

www.scientificamerican.com

 •  November 30, 2017

The Food and Drug Administration is seldom accused of being too transparent. But in late September, it looked like the agency had overshared. In an attempt to achieve the "greatest level of transparency," the agency caused the stock prices of four biotech companies to hemorrhage. Jittery traders, sifting through scraps of context-free information...

www.scientificamerican.com

 •  September 12, 2017

Four years ago, when meningitis B, an extremely rare but potentially lethal form of the infection, sickened a small number of college students at Princeton and the University of California-Santa Barbara, there was no vaccine against the disease sold in the U.S. Despite its availability abroad, it had never been licensed in the country due to its...

www.scientificamerican.com

 •  February 14, 2017

While drug companies struggle to develop medicines for rich countries and typically overlook diseases elsewhere, a robot scientist named Eve has found compounds that could fight drug-resistant malaria. Eve’s developers believe their artificial intelligence (AI) technology could speed up drug discovery, as critics call for a “match” with a live...

www.scientificamerican.com

 •  February 14, 2017

Global eradication of polio has been the ultimate game of Whack-a-Mole for the past decade; when it seems the virus has been beaten into submission in a final refuge, up it pops in a new region. Now, as vanquishing polio worldwide appears again within reach, another insidious threat may be in store from infection sources hidden in plain...